Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001415889-24-028839

Director sold 3,000 shares at an average $3.78 ($11,328)

  • Director acquired 3,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Johnston John Joseph Director 2024-12-06 Option exercise 10b5-1 +505 $2.93 $1,478 142,455 D
Johnston John Joseph Director 2024-12-06 Sale 10b5-1 −505 $3.70 $1,869 141,950 D
Johnston John Joseph Director 2024-12-09 Option exercise 10b5-1 +891 $2.93 $2,607 142,841 D
Johnston John Joseph Director 2024-12-09 Option exercise 10b5-1 +1,121 $1.64 $1,840 143,962 D
Johnston John Joseph Director 2024-12-09 Option exercise 10b5-1 +483 $2.93 $1,416 144,445 D
Johnston John Joseph Director 2024-12-09 Sale 10b5-1 −2,495 $3.79 $9,459 141,950 D
Derivatives
Johnston John Joseph Director 2024-12-06 Option exercise · Stock Option (right to buy) 10b5-1 −505 891 D
Johnston John Joseph Director 2024-12-09 Option exercise · Stock Option (right to buy) 10b5-1 −891 0 D
Johnston John Joseph Director 2024-12-09 Option exercise · Stock Option (right to buy) 10b5-1 −1,121 0 D
Johnston John Joseph Director 2024-12-09 Option exercise · Stock Option (right to buy) 10b5-1 −483 23,417 D
Open-market sales · 3,000 sh · avg $3.78 · $11,328
Loading xslF345X05/form4-12102024_041201.xml…